RH price target raised to $325 from $300 at JPMorgan 07:33 RH JPMorgan analyst Christopher Horvers raised the firm's price target on RH to $325 from $300 and keeps an Overweight rating on the shares. The analyst updated his model post the Q2 results and says second half of 2022 estimates "look beatable." Dice Therapeutics initiated with an Overweight at Cantor Fitzgerald 07:33 DICE-- Dice Therapeutics initiated with an Overweight at Cantor Fitzgerald 06:56 DICE Cantor Fitzgerald analyst Prakhar Agrawal initiated coverage of Dice Therapeutics with an Overweight rating and $36 price target. Vir Biotechnology initiated with an Outperform at SVB Securities 07:17 VIR DraftKings price target raised to $34 from $31 at Guggenheim 07:09 DKNG
Coty reinstated with a Buy rating, $12 target at BofA 06:52 COTY As previously reported, BofA analyst Anna Lizzul reinstated coverage of Coty with a Buy rating and $12 price target. Coty, one of the world's largest beauty companies, is executing on its strategic priorities laid out in 2021 to turn around its business, most notably, by increasing its sales in high-growth, high-margin prestige fragrance, beauty, and skincare, Lizzul noted. Coty has begun to stabilize and grow global market share in the Consumer Beauty segment for the last eight months, said Lizzul, who sees paths for the company to deleverage as well. ->Toast initiated with a Neutral at UBS 09:19 TOST UBS analyst Rayna Kumar… Story temporarily locked. ShowRelated Items >> ->Shift4 Payments initiated with a Buy at UBS 09:19 FOUR UBS analyst Rayna Kumar…
BUY TWLO here- $71 Twilio Inc. (TWLO) NYSE - NYSE 70.87-4.78(-6.32%) At close: September 13 04:00PM EDT 71.60+0.73(+1.03%) Pre-Market:09:27AM EDT
Moderna has held talks to supply Covid-19 vaccines to China, Reuters reports » 09:33 MRNA Moderna has held talks to…
BUY MRNA $137 Moderna, Inc. (MRNA) NasdaqGS - NasdaqGS Real Time Price. 137.38+6.08(+4.63%) As of 09:35AM EDT.
YES very strange buying at the top... I think someone might take out Dr Pepper! It's not like the soda has gotten any better. Either that or they are going to make a MONSTER purchase... if you know what I mean.